Abstract
Metabolic syndrome (MS) is a clinical condition, constituted by alterations that lead to the onset of type II diabetes and cardiovascular disease. It has been reported that orphan G-protein-coupled receptor 82 (GPR82) participates in metabolic processes. The aim of this study was to evaluate the function of GPR82 in MS using a small interfering RNA (siRNA) against this receptor. We used Wistar rats of 10–12 weeks of age fed with a high-fructose solution (70%) for 9 weeks to induce MS. Subsequently, the rats were treated with an intrajugular dose of an siRNA against GPR82 and the effects were evaluated on day 3 and 7 after administration. On day 3 the siRNA had a transient effect on decreasing blood pressure and triglycerides and increasing high-density lipoprotein cholesterol, which recovered to the MS control on day 7. Decreased gene expressions of GPR82 mRNA in the aorta and heart were observed on day 3; moreover, decreased gene expression was maintained in the aorta on day 7. Therefore, we conclude that the orphan receptor GPR82 participates in the development of MS induced by fructose and the silencing of this receptor could ameliorate metabolic components.
References
1.
Cohen
JB
, Cohen
DL
. Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome
. Curr Hypertens Rep
. 2015
May
;17
(5
):34
.
[PubMed]
1522-64172.
Zimmet
P
, Alberti
KG
, Shaw
J
. Global and societal implications of the diabetes epidemic
. Nature
. 2001
Dec
;414
(6865
):782
–7
.
[PubMed]
0028-08363.
Eckel
RH
. Preventive cardiology by lifestyle intervention: opportunity and/or challenge? Presidential address at the 2005 American Heart Association Scientific Sessions
. Circulation
. 2006
Jun
;113
(22
):2657
–61
.
[PubMed]
0009-73224.
Yubero-Serrano
EM
, Delgado-Lista
J
, Tierney
AC
, Perez-Martinez
P
, Garcia-Rios
A
, Alcala-Diaz
JF
, et al Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study
. Am J Clin Nutr
. 2015
Dec
;102
(6
):1509
–17
.
[PubMed]
0002-91655.
Reaven
GM
. Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against
. Curr Opin Lipidol
. 1997
Feb
;8
(1
):23
–7
.
[PubMed]
0957-96726.
Xiao
S
, Shaw
RM
. Cardiomyocyte protein trafficking: relevance to heart disease and opportunities for therapeutic intervention
. Trends Cardiovasc Med
. 2015
Jul
;25
(5
):379
–89
.
[PubMed]
1050-17387.
Shimabukuro
M
, Higa
M
, Yamakawa
K
, Masuzaki
H
, Sata
M
. Miglitol, α-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study
. Int J Cardiol
. 2013
Sep
;167
(5
):2108
–13
.
[PubMed]
0167-52738.
Simmons
D
. Diabetes: diabetes risk after gestational diabetes mellitus
. Nat Rev Endocrinol
. 2009
Dec
;5
(12
):646
–8
.
[PubMed]
1759-50299.
Alberti
KG
, Eckel
RH
, Grundy
SM
, Zimmet
PZ
, Cleeman
JI
, Donato
KA
, et al; International Diabetes Federation Task Force on Epidemiology and Prevention
; Hational Heart, Lung, and Blood Institute
; American Heart Association
; World Heart Federation
; International Atherosclerosis Society
; International Association for the Study of Obesity
. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
. Circulation
. 2009
Oct
;120
(16
):1640
–5
.
[PubMed]
0009-732210.
Chevalier
N
, Fénichel
P
. [Endocrine disruptors: A missing link in the pandemy of type 2 diabetes and obesity?]
. Presse Med
. 2016
Jan
;45
(1
):88
–97
.
[PubMed]
0755-498211.
Reaven
GM
. The metabolic syndrome: is this diagnosis necessary?
Am J Clin Nutr
. 2006
Jun
;83
(6
):1237
–47
.
[PubMed]
0002-916512.
Reaven
G
, Syndrome
X
. Syndrome X
. Curr Treat Options Cardiovasc Med
. 2001
Aug
;3
(4
):323
–32
.
[PubMed]
1092-846413.
Ohashi
K
, Ando
Y
, Munetsuna
E
, Yamada
H
, Yamazaki
M
, Nagura
A
, et al Maternal fructose consumption alters messenger RNA expression of hippocampal StAR, PBR, P450(11β), 11β-HSD, and 17β-HSD in rat offspring
. Nutr Res
. 2015
Mar
;35
(3
):259
–64
.
[PubMed]
0271-531714.
Davenport
AP
, Alexander
SP
, Sharman
JL
, Pawson
AJ
, Benson
HE
, Monaghan
AE
, et al International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands
. Pharmacol Rev
. 2013
May
;65
(3
):967
–86
.
[PubMed]
0031-699715.
Ruiz-Hernández
A
, Sánchez-Muñoz
F
, Rodriguez
J
, Calderón-Zamora
L
, Romero-Nava
R
, Huang
F
, et al Expression of orphan receptors GPR22 and GPR162 in streptozotocin-induced diabetic rats
. J Recept Signal Transduct Res
. 2015
Feb
;35
(1
):46
–53
.
[PubMed]
1079-989316.
Uhlenbrock
K
, Gassenhuber
H
, Kostenis
E
. Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors
. Cell Signal
. 2002
Nov
;14
(11
):941
–53
.
[PubMed]
0898-656817.
Engel
KM
, Schröck
K
, Teupser
D
, Holdt
LM
, Tönjes
A
, Kern
M
, et al Reduced food intake and body weight in mice deficient for the G protein-coupled receptor GPR82
. PLoS One
. 2011
;6
(12
):e29400
.
[PubMed]
1932-620318.
Southan
C
, Sharman
JL
, Benson
HE
, Faccenda
E
, Pawson
AJ
, Alexander
SP
, et al; NC-IUPHAR
. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
. Nucleic Acids Res
. 2016
Jan
;44
D1
:D1054
–68
.
[PubMed]
0305-104819.
Scherman
D
, Rousseau
A
, Bigey
P
, Escriou
V
. Genetic pharmacology: progresses in siRNA delivery and therapeutic applications
. Gene Ther
. 2017
Mar
;24
(3
):151
–6
.
[PubMed]
0969-712820.
Fire
A
, Xu
S
, Montgomery
MK
, Kostas
SA
, Driver
SE
, Mello
CC
. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
. Nature
. 1998
Feb
;391
(6669
):806
–11
.
[PubMed]
0028-083621.
Dong
DD
, Zhou
H
, Li
G
. GPR78 promotes lung cancer cell migration and metastasis by activation of Gαq-Rho GTPase pathway
. BMB Rep
. 2016
Nov
;49
(11
):623
–8
.
[PubMed]
1976-669622.
Stanišić
J
, Korićanac
G
, Ćulafić
T
, Romić
S
, Stojiljković
M
, Kostić
M
, et al Low intensity exercise prevents disturbances in rat cardiac insulin signaling and endothelial nitric oxide synthase induced by high fructose diet
. Mol Cell Endocrinol
. 2016
Jan
;420
:97
–104
.
[PubMed]
0303-720723.
Catak
Z
, Aydin
S
, Sahin
I
, Kuloglu
T
, Aksoy
A
, Dagli
AF
. Regulatory neuropeptides (ghrelin, obestatin and nesfatin-1) levels in serum and reproductive tissues of female and male rats with fructose-induced metabolic syndrome
. Neuropeptides
. 2014
Jun
;48
(3
):167
–77
.
[PubMed]
0143-417924.
Nakagawa
T
, Hu
H
, Zharikov
S
, Tuttle
KR
, Short
RA
, Glushakova
O
, et al A causal role for uric acid in fructose-induced metabolic syndrome
. Am J Physiol Renal Physiol
. 2006
Mar
;290
(3
):F625
–31
.
[PubMed]
1931-857X25.
Takagawa
Y
, Berger
ME
, Tuck
ML
, Golub
MS
. Impaired endothelial alpha-2 adrenergic receptor-mediated vascular relaxation in the fructose-fed rat
. Hypertens Res
. 2002
Mar
;25
(2
):197
–202
.
[PubMed]
0916-963626.
Steinberg
HO
, Chaker
H
, Leaming
R
, Johnson
A
, Brechtel
G
, Baron
AD
. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
. J Clin Invest
. 1996
Jun
;97
(11
):2601
–10
.
[PubMed]
0021-973827.
Kinote
A
, Faria
JA
, Roman
EA
, Solon
C
, Razolli
DS
, Ignacio-Souza
LM
, et al Fructose-induced hypothalamic AMPK activation stimulates hepatic PEPCK and gluconeogenesis due to increased corticosterone levels
. Endocrinology
. 2012
Aug
;153
(8
):3633
–45
.
[PubMed]
0013-722728.
Chakravarty
K
, Wu
SY
, Chiang
CM
, Samols
D
, Hanson
RW
. SREBP-1c and Sp1 interact to regulate transcription of the gene for phosphoenolpyruvate carboxykinase (GTP) in the liver
. J Biol Chem
. 2004
Apr
;279
(15
):15385
–95
.
[PubMed]
0021-925829.
Jalal
R
, Bagheri
SM
, Moghimi
A
, Rasuli
MB
. Hypoglycemic effect of aqueous shallot and garlic extracts in rats with fructose-induced insulin resistance
. J Clin Biochem Nutr
. 2007
Nov
;41
(3
):218
–23
.
[PubMed]
0912-000930.
Serkova
NJ
, Jackman
M
, Brown
JL
, Liu
T
, Hirose
R
, Roberts
JP
, et al Metabolic profiling of livers and blood from obese Zucker rats
. J Hepatol
. 2006
May
;44
(5
):956
–62
.
[PubMed]
0168-827831.
McGarry
JD
. The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homoeostasis and new insights into its molecular features
. Biochem Soc Trans
. 1995
May
;23
(2
):321
–4
.
[PubMed]
0300-512732.
Dornas
WC
, de Lima
WG
, dos Santos
RC
, Guerra
JF
, de Souza
MO
, Silva
M
, et al High dietary salt decreases antioxidant defenses in the liver of fructose-fed insulin-resistant rats
. J Nutr Biochem
. 2013
Dec
;24
(12
):2016
–22
.
[PubMed]
0955-286333.
Shulman
GI
. Cellular mechanisms of insulin resistance
. J Clin Invest
. 2000
Jul
;106
(2
):171
–6
.
[PubMed]
0021-973834.
Bergman
RN
, Ader
M
. Free fatty acids and pathogenesis of type 2 diabetes mellitus
. Trends Endocrinol Metab
. 2000
Nov
;11
(9
):351
–6
.
[PubMed]
1043-276035.
Havel
PJ
. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism
. Nutr Rev
. 2005
May
;63
(5
):133
–57
.
[PubMed]
0029-664336.
Motoyama
CS
, Pinto
MJ
, Lira
FS
, Ribeiro
EB
, do Nascimento
CM
, Oyama
LM
. Gum Guar fiber associated with fructose reduces serum triacylglycerol but did not improve the glucose tolerance in rats
. Diabetol Metab Syndr
. 2010
Oct
;2
(1
):61
.
[PubMed]
1758-599637.
Johnson
RJ
, Segal
MS
, Sautin
Y
, Nakagawa
T
, Feig
DI
, Kang
DH
, et al Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease
. Am J Clin Nutr
. 2007
Oct
;86
(4
):899
–906
.
[PubMed]
0002-916538.
Stanhope
KL
, Havel
PJ
. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans
. J Nutr
. 2009
Jun
;139
(6
):1236S
–41S
.
[PubMed]
0022-316639.
Najm
J
, Horn
D
, Wimplinger
I
, Golden
JA
, Chizhikov
VV
, Sudi
J
, et al Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum
. Nat Genet
. 2008
Sep
;40
(9
):1065
–7
.
[PubMed]
1061-403640.
Sgourakis
NG
, Bagos
PG
, Papasaikas
PK
, Hamodrakas
SJ
. A method for the prediction of GPCRs coupling specificity to G-proteins using refined profile Hidden Markov Models
. BMC Bioinformatics
. 2005
Apr
;6
(1
):104
.
[PubMed]
1471-210541.
Chi
L
, Hu
X
, Zhang
W
, Bai
T
, Zhang
L
, Zeng
H
, et al Adipokine CTRP6 improves PPARγ activation to alleviate angiotensin II-induced hypertension and vascular endothelial dysfunction in spontaneously hypertensive rats
. Biochem Biophys Res Commun
. 2017
Jan
;482
(4
):727
–34
.
[PubMed]
0006-291X42.
Guo
Q
, Xu
H
, Yang
X
, Zhao
D
, Liu
S
, Sun
X
, et al Notch activation of Ca2+-sensing receptor mediates hypoxia-induced pulmonary hypertension
. Hypertens Res
. 2017
Feb
;40
(2
):117
–29
.
[PubMed]
0916-963643.
Tiwari
S
, Siddiqi
S
, Zhelyabovska
O
, Siddiqi
SA
. Silencing of Small Valosin-containing Protein-interacting Protein (SVIP) Reduces Very Low Density Lipoprotein (VLDL) Secretion from Rat Hepatocytes by Disrupting Its Endoplasmic Reticulum (ER)-to-Golgi Trafficking
. J Biol Chem
. 2016
Jun
;291
(24
):12514
–26
.
[PubMed]
0021-925844.
Akieda-Asai
S
, Sugiyama
M
, Miyazawa
T
, Koda
S
, Okano
I
, Senba
K
, et al Involvement of guanylin and GC-C in rat mesenteric macrophages in resistance to a high-fat diet
. J Lipid Res
. 2013
Jan
;54
(1
):85
–96
.
[PubMed]
0022-2275© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
